Results 121 to 130 of about 3,384 (210)

Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care [PDF]

open access: bronze, 2019
Komal Patel   +6 more
openalex   +1 more source

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting [PDF]

open access: yes, 2017
Beitelshees, AL   +26 more
core   +1 more source

Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study

open access: green, 2010
Jörge E. Cortes   +14 more
openalex   +1 more source

The epidemiology of rasburicase use in paediatric patients with acute lymphoblastic leukaemia and non‐Hodgkin lymphoma [PDF]

open access: bronze, 2018
Rebecca Citrin   +7 more
openalex   +1 more source

Continuous hemodiafiltration during chemotherapy for acute kidney injury in spontaneous tumor lysis syndrome due to high-grade B-cell lymphoma: a case report. [PDF]

open access: yesCEN Case Rep
Kawamura N   +10 more
europepmc   +1 more source

NEW STRENGTHS: Rasburicase rys [PDF]

open access: diamond, 2004
Janette Donovan   +79 more
openalex   +1 more source

Letter to the editors regarding comments by Ghirardello et al. on the rasburicase article [PDF]

open access: bronze, 2010
David J. Hobbs   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy